77
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Familial association of lung cancer with liver cancer in first-degree relatives

, , , , , , , , & show all
Pages 5813-5819 | Published online: 28 Jun 2019

References

  • Cancer statistics. JAMA. 2013;310(9):982. doi:10.1001/jama.2013.528924002295
  • Dyzmann-Sroka A, Malicki J. Cancer incidence and mortality in the greater Poland region-analysis of the year 2010 and future trends. Rep Pract Oncol Radiother. 2014;19(5):296–300. doi:10.1016/j.rpor.2014.04.00125184053
  • Ott JJ, Ullrich A, Mascarenhas M, Stevens GA. Global cancer incidence and mortality caused by behavior and infection. J Public Health (Oxf). 2011;33(2):223–233. doi:10.1093/pubmed/fdq07620935133
  • Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol. 2014;15(12):1332–1341. doi:10.1016/S1470-2045(14)70389-425282285
  • Bermejo JL, Sundquist J, Hemminki K. Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden. Int J Cancer. 2009;124(9):2166–2171. doi:10.1002/ijc.2417819117061
  • Hiripi E, Lorenzo Bermejo J, Li X, Sundquist J, Hemminki K. Familial association of pancreatic cancer with other malignancies in Swedish families. Br J Cancer. 2009;101(10):1792–1797. doi:10.1038/sj.bjc.660536319826425
  • Jacobs EJ, Rodriguez C, Newton CC, et al. Family history of various cancers and pancreatic cancer mortality in a large cohort. Cancer Causes Control. 2009;20(8):1261–1269. doi:10.1007/s10552-009-9339-619396555
  • Moghimi-Dehkordi B, Safaee A, Vahedi M, Pourhoseingholi MA, Pourhoseingholi A, Zali MR. Population prevalence of first- and second-degree family history of breast and ovarian cancer. East Afr J Public Health. 2011;8(4):275–277.23120936
  • Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med. 2003;24(2):190–198.12568826
  • Cassidy A, Balsan J, Vesin A, et al. Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: results from a multi-centre case-control study in Europe. Eur J Cancer. 2009;45(17):3047–3053. doi:10.1016/j.ejca.2009.05.00619482469
  • Cote ML, Liu M, Bonassi S, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International lung cancer consortium. Eur J Cancer. 2012;48(13):1957–1968. doi:10.1016/j.ejca.2012.01.03822436981
  • Hemminki K, Bevier M, Sundquist J, Hemminki A. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries? Ann Oncol. 2012;23(10):2720–2724. doi:10.1093/annonc/mds06322473595
  • Jin YT, Xu YC, Yang RD, Huang CF, Xu CW, He XZ. Familial aggregation of lung cancer in a high incidence area in China. Br J Cancer. 2005;92(7):1321–1325. doi:10.1038/sj.bjc.660246515756270
  • Young RP, Hopkins RJ, Hay BA, et al. A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J. 2009;85(1008):515–524. doi:10.1136/pgmj.2008.07710719789190
  • Lin H, Zhong WZ, Yang XN, et al. A clinical model to estimate the pretest probability of lung cancer, based on 1198 pedigrees in China. J Thorac Oncol. 2012;7(10):1534–1540. doi:10.1097/JTO.0b013e3182641b8222982654
  • Hassan MM, Spitz MR, Thomas MB, et al. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol. 2009;50(2):334–341. doi:10.1016/j.jhep.2008.08.01619070394
  • Liu L, Li L, Zhou S, et al. Familial correlations of onset age of hepatocellular carcinoma: a population-based case-control family study. PLoS One. 2014;9(9):e108391. doi:10.1371/journal.pone.010839125247419
  • Yang Y, Wu QJ, Xie L, et al. Prospective cohort studies of association between family history of liver cancer and risk of liver cancer. Int J Cancer. 2014;135(7):1605–1614. doi:10.1002/ijc.2879224535817
  • Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099–2108. doi:10.1002/hep.2740625164003
  • Li X, Mutanen P, Hemminki K. Gender-specific incidence trends in lung cancer by histological type in Sweden, 1958–1996. Eur J Cancer Prev. 2001;10(3):227–235.11432709
  • Gu J, Hua F, Zhong D, Chen J, Liu H, Zhou Q. [Systematic review of the relationship between family history of lung cancer and lung cancer risk]. Zhongguo Fei Ai Za Zhi. 2010;13(3):224–229. doi:10.3779/j.issn.1009-3419.2010.03.0720673520
  • Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93(7):825–833. doi:10.1038/sj.bjc.660276916160696
  • Lo YL, Hsiao CF, Chang GC, et al. Risk factors for primary lung cancer among never smokers by gender in a matched case-control study. Cancer Causes Control. 2013;24(3):567–576. doi:10.1007/s10552-012-9994-x22729933
  • Lessel D, Vaz B, Halder S, et al. Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat Genet. 2014;46(11):1239–1244. doi:10.1038/ng.310325261934
  • Park CH, Jeong SH, Yim HW, et al. Family history influences the early onset of hepatocellular carcinoma. World J Gastroenterol. 2012;18(21):2661–2667. doi:10.3748/wjg.v18.i21.266122690075
  • Turati F, Edefonti V, Talamini R, et al. Family history of liver cancer and hepatocellular carcinoma. Hepatology. 2012;55(5):1416–1425. doi:10.1002/hep.2479422095619
  • Sellers TA, Chen PL, Potter JD, Bailey-Wilson JE, Rothschild H, Elston RC. Segregation analysis of smoking-associated malignancies: evidence for Mendelian inheritance. Am J Med Genet. 1994;52(3):308–314. doi:10.1002/ajmg.13205203117810562
  • Wu Y, Wang YY, Nakamoto Y, et al. Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver. Oncogene. 2010;29(15):2228–2237. doi:10.1038/onc.2009.50420101231